Product Description
The Infusion Pump Systems market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Infusion Pump Systems market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Infusion Pump Systems Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Infusion Pump Systems market are:
Novo Nordisk
F. Hoffmann-La Roche Ltd.
Baxter International Inc
AngioDynamics
Terumo
Teleflex Incorporated
Halyard Health
Becton, Dickinson and Company
ICU Medical Inc.
Animas Corporation (A Johnson & Johnson Company)
Moog Inc.
Becton
Zyno Medical
Smiths Group PLC
Zoll Medical
Hospira Inc. (A Pfizer Company)
B. Braun Melsungen AG
Medtronic PLC
Most important types of Infusion Pump Systems products covered in this report are:
Volumetric Infusion Pump Systems
Syringe Infusion Pump Systems
Ambulatory Infusion Pump Systems
Enteral Infusion Pump Systems
Insulin Infusion Pump Systems
Implantable Infusion Pump Systems
Anesthesia Infusion Pump Systems
Chemotherapy Infusion Pump Systems
Most widely used downstream fields of Infusion Pump Systems market covered in this report are:
Hospitals
Ambulatory
Home Healthcare
Clinics
Others
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.